Results 181 to 190 of about 5,076 (215)
Some of the next articles are maybe not open access.
Development of Mycoplasma hyopneumoniae Recombinant Vaccines
2016Mycoplasma hyopneumoniae is the etiological agent of swine enzootic pneumonia (EP), a disease that affects swine production worldwide. Vaccination is the most cost-effective strategy for the control and prevention of the disease. Research using genome-based approach has the potential to elucidate the biology and pathogenesis of M.
Silvana Beutinger, Marchioro +2 more
openaire +2 more sources
Response of Swine to Mycoplasma hyopneumoniae Infection
Journal of Infectious Diseases, 1973Mycoplasmal pneumonia of swine offers a useful and economically significant model to study many aspects of chronic mycoplasmal pneumonia. Although the available information is very meager about areas of this disease, there are some very interesting aspects to this model. Infection with Mycoplasma hyopneumoniae is common in swine.
openaire +2 more sources
Research in Veterinary Science, 1991
Cells of Mycoplasma flocculare were found to vary in size and shape, especially in the later phases of growth, whereas those of Mycoplasma hyopneumoniae were fairly uniform irrespective of growth phases. Filamentous cells were present in cultures of M flocculare in the stationary and declining phases, but were never found in cultures of M hyopneumoniae.
K, Hovind-Hougen, N F, Friis
openaire +2 more sources
Cells of Mycoplasma flocculare were found to vary in size and shape, especially in the later phases of growth, whereas those of Mycoplasma hyopneumoniae were fairly uniform irrespective of growth phases. Filamentous cells were present in cultures of M flocculare in the stationary and declining phases, but were never found in cultures of M hyopneumoniae.
K, Hovind-Hougen, N F, Friis
openaire +2 more sources
Intraperitoneal vaccination of pigs to control Mycoplasma hyopneumoniae
Research in Veterinary Science, 1991In a field trial at a commercial piggery 22 pigs were vaccinated intraperitoneally, at 30 days and 60 days old, with formalin-killed Mycoplasma hyopneumoniae plus adjuvant. Two other groups of the same size, one receiving a ration containing antibiotics, were not vaccinated.
R F, Sheldrake +3 more
openaire +2 more sources
A concise review of vaccines against Mycoplasma hyopneumoniae
Research in Veterinary Science, 2019Mycoplasma hyopneumoniae (Mhp) is the pathogen of Mycoplasmal pneumonia of swine (MPS), a chronic respiratory infectious discease which causes enormous losses to the swine industry worldwide. At present, vaccination is the most effective mean to prevent and reduce economic losses caused by this pathogen.
Yu Tao +4 more
openaire +2 more sources
Evaluation of virulence of Mycoplasma hyopneumoniae field isolates
Veterinary Microbiology, 2003The course of enzootic pneumonia, caused by Mycoplasma hyopneumoniae, is strongly influenced by management and housing conditions. Other factors, including differences in virulence between M. hyopneumoniae strains, may also be involved. The aim of this study was to evaluate the virulence of six M.
J, Vicca +6 more
openaire +2 more sources
Protein variability among Mycoplasma hyopneumoniae isolates
Veterinary Microbiology, 2007Sodium-dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to study the protein variability of Mycoplasma hyopneumoniae isolates. Fifty-six M. hyopneumoniae isolates from 6 different countries and 37 different herds were used. From eight herds, more than one isolate was available.
D, Calus +7 more
openaire +2 more sources
Comparison of Mycoplasma hyopneumoniae strains by serologic methods
American Journal of Veterinary Research, 1983SUMMARY Six field strains of Mycoplasma hyopneumoniae isolated from pneumonic lungs of pigs, reference strains 11 and J of M hyopneumoniae, Ms 42 strain of Mycoplasma flocculare, and BTS 7 strain of Mycoplasma hyorhinis were compared serologically, using hyperimmune antisera produced in rabbits.
L H, Ro, R F, Ross
openaire +2 more sources
Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine
American Journal of Veterinary Research, 1984SUMMARY Protective activity of Mycoplasma hyopneumoniae vaccines prepared from whole cells or crude extracts was evaluated in an experimentally induced mycoplasmal pneumonia swine model. Swine were obtained at 7 to 10 weeks of age from a surgically derived herd free of porcine mycoplasmas.
R F, Ross +2 more
openaire +2 more sources
Mycoplasma hyopneumoniae-induced disease.
CABI Reviews, 2007Abstract Respiratory disease remains a significant problem to the swine industry. In most production systems, multiple pathogens and their interactions are responsible for the pneumonia and reduced productivity that are observed.
openaire +1 more source